Table 1.
Number | N | τD (μs) | DM (μm2/s) | |
---|---|---|---|---|
1 | Control | 0 | 777 ± 39 | 8.1 ± 0.4 |
2 | L-lysine | 1 | 735 ± 37 | 8.5 ± 0.4 |
3 | Pentalysine | 5 | 1176 ± 59 | 5.4 ± 0.3 |
4 | PLL | 20 | 1870 ± 94 | 3.4 ± 0.2 |
5 | PLL (unilateral) | 126 | 1763 ± 88 | 3.6 ± 0.2 |
6 | +PLL (bilateral) | 126 | 3576 ± 179 | 1.8 ± 0.1 |
7 | +1 M KCl | 126 | 1278 ± 64 | 4.9 ± 0.2 |
Except number 5, PLL was present in both compartments. Numbers 5–7 denote subsequent additions. The conditions were as noted in Fig. 1.
PLL, poly-lysine; τD, residence time in the focus; Rh-PE, rhodamine labeled phosphatidylethanolamine; N, number of lysine units; DM, lipid diffusion coefficient.